Oncology Intelligence Digest July 10, 2026 GSK and Hansoh reported that their B7-H3-targeted antibody-drug conjugate risvutatug rezetecan (ris-rez)…
Oncology Intelligence Membership Required
You must be a Oncology Intelligence member to access this content.
Already a member? Log in here